文献速递眼底病与葡萄膜炎

LPA1通过USP1介导ZEB1去泛素化稳定促进RPE上皮间质转化及视网膜下纤维化

LPA1-Induced EMT of Retinal Pigment Epithelial Cells Promotes Subretinal Fibrosis via USP1-Mediated Deubiquitination and Stabilization of ZEB1.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究在C57BL/6J小鼠两阶段激光损伤模型中探究LPA1在视网膜下纤维化(SRF)中的作用。LPA1通过增加USP1表达、减少ZEB1泛素化并稳定ZEB1,促进视网膜色素上皮(RPE)细胞上皮间质转化(EMT)和迁移;BMS-986278抑制LPA1可减轻SRF严重程度,且对纤维化病变的抑制强于新生血管病变。

要点

  • LPA1在激光诱导SRF中上调,并与纤维化标志物表达增加相关。
  • LPA1通过USP1/ZEB1轴促进RPE细胞EMT和迁移。
  • BMS-986278抑制LPA1可减轻SRF,对纤维化病变抑制强于新生血管病变。

核心结论

  • LPA1通过USP1介导的ZEB1去泛素化与稳定驱动RPE细胞EMT,从而促进SRF。
  • 靶向LPA1/USP1/ZEB1轴可能为nAMD相关SRF提供有前景的治疗策略。

研究设计与样本

  • 采用C57BL/6J小鼠两阶段激光损伤模型诱导SRF。
  • 通过western blotting和免疫荧光评估LPA1表达及其对USP1和ZEB1的调控。
  • 通过迁移实验和纤维化标志物分析评估RPE细胞EMT。
  • 进行ZEB1和USP1功能缺失实验以明确其作用。
  • 采用分子对接和共免疫沉淀检查USP1介导的ZEB1去泛素化,并在体内评估BMS-986278抑制LPA1的抗纤维化效果与安全性。

主要发现

  • LPA1在激光诱导SRF中上调,并与纤维化标志物表达增加相关。
  • LPA1过表达通过USP1/ZEB1轴促进RPE细胞EMT和迁移。
  • LPA1增加USP1表达,USP1通过减少ZEB1泛素化稳定ZEB1并促进其核转位。
  • 抑制USP1可减轻LPA1诱导的EMT和纤维化,效果与沉默ZEB1相似。
  • 体内BMS-986278抑制EMT并降低SRF严重程度,对纤维化病变的抑制作用强于对新生血管病变。

关键数值与推荐

  • 在C57BL/6J小鼠两阶段激光损伤模型中,LPA1上调并与纤维化标志物表达增加相关。
  • LPA1过表达通过USP1/ZEB1轴促进RPE细胞EMT和迁移。
  • USP1抑制减轻LPA1诱导的EMT和纤维化,效果与ZEB1沉默相似。
  • BMS-986278在体内抑制EMT并降低SRF严重程度,对纤维化病变的抑制作用强于对新生血管病变。

临床怎么用

  • LPA1/USP1/ZEB1轴可作为nAMD相关SRF的潜在治疗靶点。
  • BMS-986278抑制LPA1在模型中减轻SRF,且对纤维化病变抑制更强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Subretinal fibrosis (SRF) is a vision-threatening complication of neovascular age-related macular degeneration (nAMD), yet effective antifibrotic strategies remain limited. This study investigated the role of lysophosphatidic acid receptor 1 (LPA1), a fibrosis-associated G protein-coupled receptor, in SRF progression and evaluated its therapeutic potential. METHODS: A two-stage laser injury model was used to induce SRF in C57BL/6J mice. LPA1 expression and its regulation of ubiquitin-specific peptidase 1 (USP1) and zinc finger E-box binding homeobox 1 (ZEB1) were assessed by western blotting and immunofluorescence. Retinal pigment epithelial (RPE) cell epithelial-mesenchymal transition (EMT) was evaluated by migration assays and fibrotic marker analysis. ZEB1 and USP1 loss-of-function experiments were performed to define their roles. Molecular docking and co-immunoprecipitation were used to examine USP1-mediated ZEB1 deubiquitination. The antifibrotic effects and the safety of LPA1 inhibition by BMS-986278 were assessed in vivo. RESULTS: LPA1 was upregulated in laser-induced SRF and was associated with increased fibrotic marker expression. LPA1 overexpression promoted RPE EMT and migration through the USP1/ZEB1 axis. Mechanistically, LPA1 increased USP1 expression, which stabilized ZEB1 and promoted its nuclear translocation by reducing ZEB1 ubiquitination. USP1 inhibition attenuated LPA1-induced EMT and fibrosis, similar to ZEB1 silencing. In vivo, BMS-986278 suppressed EMT and reduced SRF severity, with a stronger inhibitory effect on fibrotic lesions than on neovascular lesions. CONCLUSIONS: LPA1 promotes SRF by driving RPE EMT through USP1-mediated deubiquitination and stabilization of ZEB1. Targeting the LPA1/USP1/ZEB1 axis may provide a promising therapeutic strategy for nAMD-associated SRF.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhu M, Cui L, Guo Y, et al. LPA1-Induced EMT of Retinal Pigment Epithelial Cells Promotes Subretinal Fibrosis via USP1-Mediated Deubiquitination and Stabilization of ZEB1. Invest Ophthalmol Vis Sci. 2026. PMID: 42593178. doi:10.1167/iovs.67.10.34

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。